Denervación renal para el tratamiento de la hipertensión arterial resistente en España. Registro Flex-Spyral

Rodriguez-Leor, Oriol; Segura, Julián; García Donaire, José Antonio; Gutiérrez-Ibañes, Enrique; Oliveras, Anna; Mediavilla, Juan Diego; Serrador, Ana; Prado, José Carlos; Nuñez-Gil, Iván; Díez-Delhoyo, Felipe; Velasco, Albert Clarà; Jaén Águila, Fernando; Amat-Santos, Ignacio; Bayes-Genis, Antoni; Troya Saborido, María Isabel.
Rev. esp. cardiol. (Ed. impr.) ; 73(8): 615-622, ago. 2020. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-198247

Documentos relacionados

  1. Los registros de denervación renal, ¿completan la evidencia?
  2. Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program.
  3. Differential effects of renal denervation on skin and muscle sympathetic nerve traffic in resistant and uncontrolled hypertension.
  4. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial.
  5. Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
  6. A home and ambulatory artificial nutrition (NADYA) Group Report, Home Parenteral Nutrition in Spain, 2013
  7. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
  8. Renal denervation: recent developments in clinical and preclinical research.
  9. [Renal denervation : Really an alternative to reducing blood pressure?]
  10. Use of a pulsatile perfusion pump for renal autotransplantation in a patient undergoing thoracoabdominal bypass for malignant hypertension secondary to Takayasu arteritis.